![Tsuguo Sasaki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tsuguo Sasaki
Directeur/Membre du Conseil chez Japan BCG Laboratory KK
Postes actifs de Tsuguo Sasaki
Sociétés | Poste | Début | Fin |
---|---|---|---|
Japan BCG Laboratory KK
![]() Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Tsuguo Sasaki
Statistiques
Internationale
Japon | 2 |
Opérationnelle
Director/Board Member | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Japan BCG Laboratory KK
![]() Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | Health Technology |
- Bourse
- Insiders
- Tsuguo Sasaki
- Expérience